Skip to main content

CORRECTION article

Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1447095

Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transitionin ovarian cancer

Provisionally accepted
Ting Lan Ting Lan 1,2*Hui-Wen Yang Hui-Wen Yang 1,2*Yan Lan Yan Lan 3*An Li An Li 2*Han Wu Han Wu 2*Zi-Wei Song Zi-Wei Song 1*Ai-Ling Wan Ai-Ling Wan 1*Yue Wang Yue Wang 2*Shibao Li Shibao Li 2Shuai Ji Shuai Ji 4Zhong- Cheng Wang Zhong- Cheng Wang 3*Xin-Yu Wu Xin-Yu Wu 5*
  • 1 School of Medical Technology, Xuzhou Medical University, Xuzhou, China
  • 2 Xuzhou Key Laboratory of Laboratory Diagnostics, Xuzhou Medical University, Xuzhou, Jiangsu Province, China
  • 3 Department of Pathophysiology, School of Basic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu Province, China
  • 4 School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu Province, China
  • 5 Department of Laboratory Medicine,Affiliated Xuzhou Maternity and Child Health Care Hospital of Xuzhou Medical University, Xuzhou, China., Xuzhou, Jiangsu Province, China

This article is a correction to:

  1. Myricetin Induces Autophagy and Cell Cycle Arrest of HCC by Inhibiting MARCH1-Regulated Stat3 and p38 MAPK Signaling Pathways

    1. Read original article

The final, formatted version of the article will be published soon.

    • please read through all the templates before choosing• pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below.• please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary• submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.

    Keywords: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition Frontiers Media SA myricetin, epithelial-to-mesenchymal transition, TGF-β, ovarian cancer, PI3K/AKT， TGF-β/Smad

    Received: 11 Jun 2024; Accepted: 10 Oct 2024.

    Copyright: © 2024 Lan, Yang, Lan, Li, Wu, Song, Wan, Wang, Li, Ji, Wang and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Ting Lan, School of Medical Technology, Xuzhou Medical University, Xuzhou, China
    Hui-Wen Yang, School of Medical Technology, Xuzhou Medical University, Xuzhou, China
    Yan Lan, Department of Pathophysiology, School of Basic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu Province, China
    An Li, Xuzhou Key Laboratory of Laboratory Diagnostics, Xuzhou Medical University, Xuzhou, Jiangsu Province, China
    Han Wu, Xuzhou Key Laboratory of Laboratory Diagnostics, Xuzhou Medical University, Xuzhou, Jiangsu Province, China
    Zi-Wei Song, School of Medical Technology, Xuzhou Medical University, Xuzhou, China
    Ai-Ling Wan, School of Medical Technology, Xuzhou Medical University, Xuzhou, China
    Yue Wang, Xuzhou Key Laboratory of Laboratory Diagnostics, Xuzhou Medical University, Xuzhou, Jiangsu Province, China
    Zhong- Cheng Wang, Department of Pathophysiology, School of Basic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu Province, China
    Xin-Yu Wu, Department of Laboratory Medicine,Affiliated Xuzhou Maternity and Child Health Care Hospital of Xuzhou Medical University, Xuzhou, China., Xuzhou, Jiangsu Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.